DE69232875T2 - MHC-Konjugate zur Verbesserung der Autoimmunität. - Google Patents

MHC-Konjugate zur Verbesserung der Autoimmunität.

Info

Publication number
DE69232875T2
DE69232875T2 DE69232875T DE69232875T DE69232875T2 DE 69232875 T2 DE69232875 T2 DE 69232875T2 DE 69232875 T DE69232875 T DE 69232875T DE 69232875 T DE69232875 T DE 69232875T DE 69232875 T2 DE69232875 T2 DE 69232875T2
Authority
DE
Germany
Prior art keywords
improve autoimmunity
mhc
conjugates
mhc conjugates
autoimmunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69232875T
Other languages
English (en)
Other versions
DE69232875D1 (de
Inventor
R Clark
D Sharma
L Lerch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coulter Pharmaceutical Inc
Original Assignee
Anergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/690,840 external-priority patent/US5260422A/en
Priority claimed from US07/869,293 external-priority patent/US5468481A/en
Application filed by Anergen Inc filed Critical Anergen Inc
Application granted granted Critical
Publication of DE69232875D1 publication Critical patent/DE69232875D1/de
Publication of DE69232875T2 publication Critical patent/DE69232875T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

DE69232875T 1991-04-23 1992-04-23 MHC-Konjugate zur Verbesserung der Autoimmunität. Expired - Fee Related DE69232875T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/690,840 US5260422A (en) 1988-06-23 1991-04-23 MHC conjugates useful in ameliorating autoimmunity
US07/869,293 US5468481A (en) 1988-06-23 1992-04-14 MHC class II-peptide conjugates useful in ameliorating autoimmunity
PCT/US1992/003391 WO1992018150A1 (en) 1991-04-23 1992-04-23 Mhc conjugates useful in ameliorating autoimmunity

Publications (2)

Publication Number Publication Date
DE69232875D1 DE69232875D1 (de) 2003-01-30
DE69232875T2 true DE69232875T2 (de) 2003-08-21

Family

ID=27104684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232875T Expired - Fee Related DE69232875T2 (de) 1991-04-23 1992-04-23 MHC-Konjugate zur Verbesserung der Autoimmunität.

Country Status (3)

Country Link
EP (1) EP0630255B1 (de)
JP (1) JP2003231698A (de)
DE (1) DE69232875T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101678090B (zh) * 2007-03-07 2012-04-11 乌第有限合伙公司 用于预防和治疗自身免疫病的组合物和方法
EP2155782A2 (de) 2007-03-26 2010-02-24 Dako Denmark A/S Mhc-peptid-komplexe und anwendungen davon bei infektionskrankheiten
EP2167537A2 (de) 2007-07-03 2010-03-31 Dako Denmark A/S Zusammengestellte verfahren für die analyse und sortierung von proben
EP2197908A2 (de) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
GB0919751D0 (en) * 2009-11-11 2009-12-30 King S College Hospital Nhs Fo Conjugate molecule
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
ES2730273T3 (es) 2013-11-04 2019-11-11 Uti Lp Métodos y composiciones para inmunoterapia sostenida

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
JPH07501526A (ja) * 1991-11-19 1995-02-16 アナージェン，インコーポレイティド 有害な免疫応答の改善において有用なｍｈｃサブユニット結合体

Also Published As

Publication number Publication date
EP0630255A4 (de) 1995-04-19
JP2003231698A (ja) 2003-08-19
DE69232875D1 (de) 2003-01-30
EP0630255A1 (de) 1994-12-28
EP0630255B1 (de) 2002-12-18

Similar Documents

Publication Publication Date Title
DE68908909D1 (de) Kabelbinder.
DE69126606D1 (de) Vakzine
DE69317474T2 (de) Abbaubarer Verbundstoff
DE3871335D1 (de) Laengsvergleichsschutzsystem.
DE69007311T2 (de) Konjugate.
MX9201770A (es) Mejoras relacionadas con las secciones de plastificacion.
DE69114940T2 (de) Multifunktionsanzeigesystem.
NO924284D0 (no) Polycykliske konjugater
DE69232875T2 (de) MHC-Konjugate zur Verbesserung der Autoimmunität.
FI923238A0 (fi) Cysteinamid innehaollande permanent.
DE59102503D1 (de) Kanüle.
DE59203524D1 (de) Alkandiolbisacetale.
NO921807D0 (no) Brennstoffsammensetning
DE69300896D1 (de) Ziele.
ITMI921226A1 (it) Rincalzatrice
BR9106587A (pt) Barra de conexao
DE69123256D1 (de) Antigen-antikörperkonjugaten
KR920015151U (ko) 경사 준비용 크리일
IT223409Z2 (it) Fermacravatte.
ATE94266T1 (de) Kabelbinder.
FI742U1 (fi) Koppling foer kabeln till en svetsbraennare
DE9117136U1 (de) Widerlager
KR930014523U (ko) 괘지고리를 형성한 열쇠
ES1014627Y (es) Banderin perfeccionado.
ID1028B (id) Vaksin

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: COULTER PHARMACEUTICAL, INC., SEATTLE, WASH., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee